Discover trends, market shifts, and competitive outlooks for the idefirix global market report 2025 industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Projected Market Size and Growth Rates for the Idefirix Market From 2025 To 2029?#_x000D_

In recent times, the market size of idefirix has grown at a remarkable XX (HCAGR). The market is projected to expand from a size of $XX million in 2024 to $XX million in 2025, exhibiting a compound annual growth rate (CAGR) of XX%. Factors contributing to this significant growth during the historical phase include an increased occurrence of allergic diseases, heightened dosage of the drug, a surge in chronic diseases’ prevalence, a rising demand for organ transplantations, and an upswing in prevalence and incidence of kidney diseases._x000D_

_x000D_

In the coming years, the market size of Idefirix is projected to experience a XX (FCAGR) increment. By 2029, it is anticipated to increase to $XX million with a Compound Annual Growth Rate (CAGR) of XX%. The surge during the forecast period can be credited to factors like a growing kidney waiting list, heightened awareness about organ donation, expansion in research and development, an increase in the number of procedures and FDA approvals, as well as a rise in awareness about antibody-mediated rejection. The forecast period will likely see a lot of significant trends, such as the improvement of antibody-cleaving enzyme technology, increased funding for transplant immunology research, partnerships with transplant centers for clinical integration, an increased emphasis on personalized medicine, and state initiatives promoting organ transplantation._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=20093&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Idefirix Industry?#_x000D_

The idefirix market is projected to expand due to the rising prevalence and incidence of kidney diseases. Kidney diseases, which can impair the kidneys’ ability to filter waste and maintain the body’s fluid balance, are spreading due to factors such as an aging population, increased diabetes and hypertension rates, lifestyle choices, and genetic predispositions. Idefirix, an advanced IgG-degrading enzyme therapy, provides kidney disease patients the opportunity to receive vital kidney transplants by effectively lowering the donor-specific antibodies that could lead to transplant rejection. For example, a UK-based kidney research report published in June 2023 suggested that the number of acute kidney injury cases is expected to rise from an estimated 615,000 in 2022 to 637,000 by 2033. Thus, the growth of the idefirix market is being fueled by the escalating prevalence and incidence of kidney diseases._x000D_

_x000D_

#How Is the Idefirix Market Segmented?#_x000D_

The idefirix market covered in this report is segmented –_x000D_

_x000D_

1) By Patient Demographics: Pediatric Patients, Adult Patients_x000D_

2) By Application: Kidney Transplantation, Desensitization Protocols_x000D_

3) By End-User: Hospitals, Specialized Clinics, Home Healthcare_x000D_

4) By Distribution Channel: Direct Sales, Pharmacies_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=20093&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Idefirix Market Growth?#_x000D_

Europe was the largest region in the idefirix market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the idefirix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Idefirix Industry?#_x000D_

One of the prominent trends in the idefirix market is the emphasis on creating novel treatments, such as desensitization methods, for highly sensitized patients awaiting kidney transplants. Desensitization involves a medical procedure that eliminates or minimizes damaging antibodies, allowing transplant recipients to accept organs from non-matching donors. In July 2023, an announcement was made by the biopharmaceutical firm Hansa Biopharma, based in Sweden, stating that the Australian Therapeutic Goods Administration (TGA) had approved Idefirix (imlifidase) for use as a desensitization method for highly sensitized kidney transplant patients. This approval permits these patients to accept kidney donations from both living and deceased donors. The procedure functions by minimizing or eliminating dangerous anti-donor antibodies which could otherwise hinder the transplantation process. This approval, based on the positive outcomes from phase 2 studies conducted by Hansa Biopharma, signifies a substantial advancement in widening kidney transplant opportunities for highly sensitized patients in Australia._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/idefirix-global-market-report_x000D_

_x000D_

#How Is the Idefirix Market Defined and What Are Its Core Parameters?#_x000D_

Idefirix (imlifidase) is an enzyme-based medication designed to reduce donor-specific antibodies in highly sensitized kidney transplant patients, enabling successful organ transplantation. It is used to desensitize patients awaiting kidney transplants by cleaving IgG antibodies, increasing compatibility with available donors._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20093_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model